Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
1.0 |
High Similarity |
NPD6166 |
Phase 2 |
1.0 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
1.0 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9355 |
High Similarity |
NPD1934 |
Approved |
0.9264 |
High Similarity |
NPD7074 |
Phase 3 |
0.9207 |
High Similarity |
NPD6797 |
Phase 2 |
0.9202 |
High Similarity |
NPD7054 |
Approved |
0.9172 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9152 |
High Similarity |
NPD7251 |
Discontinued |
0.9146 |
High Similarity |
NPD7472 |
Approved |
0.9096 |
High Similarity |
NPD7808 |
Phase 3 |
0.8976 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8938 |
High Similarity |
NPD3882 |
Suspended |
0.8938 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8931 |
High Similarity |
NPD2801 |
Approved |
0.8875 |
High Similarity |
NPD3817 |
Phase 2 |
0.8869 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8846 |
High Similarity |
NPD1512 |
Approved |
0.8795 |
High Similarity |
NPD3818 |
Discontinued |
0.8743 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8742 |
High Similarity |
NPD4380 |
Phase 2 |
0.8718 |
High Similarity |
NPD1511 |
Approved |
0.865 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.865 |
High Similarity |
NPD7075 |
Discontinued |
0.8606 |
High Similarity |
NPD6959 |
Discontinued |
0.8545 |
High Similarity |
NPD5494 |
Approved |
0.8544 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8528 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8412 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8405 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8397 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8333 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8294 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.825 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8242 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.821 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8161 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8153 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8133 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8129 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8086 |
Intermediate Similarity |
NPD5401 |
Approved |
0.807 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8065 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8065 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7949 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7931 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7907 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7861 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7849 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7848 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7845 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD919 |
Approved |
0.7834 |
Intermediate Similarity |
NPD943 |
Approved |
0.7829 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7824 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7765 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7765 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7742 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7622 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7607 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7566 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7562 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7545 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD37 |
Approved |
0.7541 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7526 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7514 |
Intermediate Similarity |
NPD4965 |
Approved |
0.75 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7455 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7453 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7448 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7448 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7448 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD7697 |
Approved |
0.744 |
Intermediate Similarity |
NPD2534 |
Approved |
0.744 |
Intermediate Similarity |
NPD2532 |
Approved |
0.744 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7409 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7409 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7378 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7363 |
Intermediate Similarity |
NPD7240 |
Approved |
0.736 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7302 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7302 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7302 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7301 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7296 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7277 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD920 |
Approved |
0.7245 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7244 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7212 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7198 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD7801 |
Approved |
0.716 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7135 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7081 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7081 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7077 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7077 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7072 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7069 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7041 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD2403 |
Approved |
0.703 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7017 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7017 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7017 |
Intermediate Similarity |
NPD5711 |
Approved |
0.699 |
Remote Similarity |
NPD3450 |
Approved |
0.699 |
Remote Similarity |
NPD3452 |
Approved |
0.6989 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6982 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6977 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6977 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6975
|
Remote Similarity |
NPD2861 |
Phase 2 |